全部分类
  • VH-298
VH-298的可视化放大

VH-298

A cell-permeant inhibitor of VHL

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

VH-298的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 2mg
    ¥562.00
    450.00
    - +
  • 5mg
    ¥800.00
    640.00
    - +
  • 10mg
    ¥1300.00
    1040.00
    - +
  • 50mg
    ¥3600.00
    2880.00
    - +
  • 100mg
    ¥5400.00
    4320.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci22992
  • CAS: 2097381-85-4
  • 别名:
  • 分子式: C27H33N5O4S
  • 分子量: 523.65
  • 纯度: >98%
  • 溶解度: DMSO : ≥ 83.3 mg/mL (159.08 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

VH-298 is a highly potent inhibitor of the VHL:HIF-α interaction with a Kd value of 80 to 90 nM, used in PROTAC technology.


VH-298 is a potent, cell permeable and non-toxic chemical probe that triggers the hypoxic response by blocking the VHL. VH-298 is a highly potent inhibitor of the VHL:HIF-α interaction with Kd values of 90 and 80 nM in isothermal titration calorimetry and competitive fluorescence polarization assay. VH-298 binds with VHL complex very fast and dissociates slowly. VH-298 at 50 uM concentration exhibits negligible off-target effects in vitro against more than 100 tested cellular kinases, GPCRs and ion channels. VH-298 is cell permeable and not toxic to cells. The measured permeability of VH-298 is found to be 19.4 nm s -1. VH-298 induces concentration- and time-dependent on-target specific accumulation of hydroxylated HIF-α in human cell lines, including HeLa cancer cells and renal cell carcinoma 4 (RCC4) cells. VH-298 increases mRNA levels of EPO by 2.5-fold in RCC4-HA-VHL, but not in VHL-null RCC4-HA, indicating that pharmacological inhibition of VHL is able to stimulate endogenous EPO synthesis. VH-298 proves as effective as hypoxia in raising PHD2 and HK2 protein levels, however in HFF the BNIP3 protein level increases more with VH-298 treatment than hypoxia treatment[1].

参考文献:
[1]. Frost J, et al. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition. Nat Commun. 2016 Nov 4;7:13312.

Protocol

Kinase experiment:

VH-298 is screened at 50 μM concentration against a panel of 50 kinases. The remaining kinase activity is recorded in the end of the assay. The data is reported as average % activity remaining of assay duplicates for each kinase tested[1].

Cell experiment:

Death of CTLs is analyzed by staining with 4′,6-diamidino-2-phenylindole (DAPI). Cells are plated in 96-well plates at 1×106 and treated with VHL inhibitors (VH-298) and respective non-binding cis-analogues for 24?h. Cells are spun down and resuspended in HBSS containing DAPI to identify dead and dying populations[1].

参考文献:

[1]. Frost J, et al. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition. Nat Commun. 2016 Nov 4;7:13312.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算